Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LFT Dye Monitor System vs Serial Blood Draws for Liver Function
NCT02552901Phase 3Withdrawn
- Sponsor
- Cardiox
- Start
- Nov 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 3, open-label trial (2 arms), sponsored by Cardiox. Primary endpoint: plasma disappearance rate. Planned start Nov 2015; status: withdrawn.
Beyond the preview
Go deeper on NCT02552901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552901.